1 not yet recruiting, 1 unknown. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Not yet recruiting 1, Unknown 1 |
Follow Acromegaly Due to Pituitary Adenoma: new trials by email Literature Review of Acromegaly Due to Pituitary Adenoma trials Research Report on Acromegaly Due to Pituitary Adenoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PRESTO: A Phase III Randomised Controlled Trial of Dose-escalated Proton Beam Therapy Versus Standard of Care Radiotherapy for Functioning Pituitary Tumours Standard dose Intensity-Modulated Radiation Therapy (IMRT), Standard dose Proton Beam Therapy (PBT), Escalated dose Proton Beam Therapy (PBT) - Acromegaly Due to Pituitary Adenoma, Cushing's Disease | Phase 3 | Not yet recruiting | University College, London | 82 | 2026-09-01 | 2026-10-01 |
| Multicenter Evaluation of the Effect of Upfront Radiosurgery on Residual Growth Hormone-secreting Pituitary Adenoma Gamma knife radiosurgery, Lanreotide 60Mg Solution for Injection - Acromegaly Due to Pituitary Adenoma | Phase 3 | Unknown | Samsung Medical Center | 90 | 2018-03-01 | 2018-03-01 |
Acromegaly (2) · Growth Hormone-Secreting Pituitary Adenoma (2) · Pituitary Neoplasms (2) · Adenoma (1) · Pituitary ACTH Hypersecretion (1) · Pituitary Diseases (1)
Bone Diseases (2) · Bone Diseases, Endocrine (2) · Brain Diseases (2) · Brain Neoplasms (2) · Central Nervous System Diseases (2) · Central Nervous System Neoplasms (2) · Endocrine Gland Neoplasms (2) · Endocrine System Diseases (2) · Hyperpituitarism (2) · Hypothalamic Diseases (2) · Hypothalamic Neoplasms (2) · Musculoskeletal Diseases (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms by Site (2)
Injections (1) · Proton Therapy (1) · Radiosurgery (1) · Radiotherapy, Intensity-Modulated (1) · Solutions (1) · lanreotide (1)
Samsung Medical Center (1) · University College, London (1)
South Korea (1)
Michael Kosmin (1)